METFORMIN THERAPY IN TYPE 2 DIABETES: A SIX-MONTH OBSERVATIONAL STUDY ON GLYCEMIC CONTROL, LIPID PROFILE, AND SAFETY. Tr. Biosci. Res. 2024, 1 (01), 13-18.